Daniel Mukasa net worth
Quick answer
Daniel Mukasa's estimated net worth is $12.0M (range $8.4M – $18.0M) as of 2026. Daniel Mukasa is CEO at AbInitio Bio. AbInitio Bio valuation.
Daniel Mukasa is CEO at AbInitio Bio (YC P26). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: N/A
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 2
- Website: https://www.abinitio-bio.com
Who is Daniel Mukasa?
Daniel Mukasa is a co-founder of AbInitio Bio, a company focused on developing therapies for cancer and other diseases.
Highlights:
- Harvard University
- MIT
- N/A
About AbInitio Bio
Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
FAQ: Daniel Mukasa net worth and AbInitio Bio valuation
What is Daniel Mukasa's net worth?
Daniel Mukasa's estimated net worth is $12.0M (range $8.4M – $18.0M) as of 2026. Daniel Mukasa is CEO at AbInitio Bio. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is AbInitio Bio valuation?
AbInitio Bio's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Daniel Mukasa's role?
Daniel Mukasa is CEO at AbInitio Bio, a Y Combinator-backed startup (batch P26).